The study tests upadacitinib, an oral tablet, and dupilumab, a subcutaneous injection, to determine their effectiveness in treating atopic dermatitis. The goal is to assess whether upadacitinib can ...

Patients with type 2 diabetes and atopic dermatitis show higher risk for cardiovascular events, but GLP-1 agonists reduce the ...

Nektar Therapeutics is fairly valued based on rNPV modeling, but multiple near-term catalysts could drive upside. Learn why ...

Discover a study showing how online clustered nursing care improves symptoms and enhances sleep quality in adults with atopic dermatitis.